Gibson Study Showcased at National Kidney Foundation’s Annual Spring Meeting
The National Kidney Foundation showcased a global study led by Keisha Gibson, MD, MPH, chief of pediatric nephrology, designed to understand the experimental immunosuppressant drug Voclosporin as a treatment for patients with lupus kidney disease. The study “AURORA Phase 3 Trial Demonstrates Voclosporin Statistical Superiority Over Standard of Care in Lupus Nephritis (LN)” was selected as a … Continued